Meteora Capital’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,452	Closed	-$59.2K	–	398
2023 Q1	$59.2K	Hold	13,452	–	–	0.01%	258
2022 Q4	$79.4K	Sell	13,452 -11,501	-46%	-$67.8K	0.02%	199
2022 Q3	$175K	Sell	24,953 -4,301	-15%	-$30.2K	0.04%	193
2022 Q2	$424K	Buy	+29,254	New	+$424K	0.08%	178